성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Chronic Complications of Diabetes Mellitus | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Chronic Complications of Diabetes Mellitus

NCLEX Review Guide: Chronic Complications of Diabetes Mellitus

Pathophysiology of Diabetic Complications

Mechanisms of Tissue Damage

  • Chronic hyperglycemia leads to microvascular and macrovascular damage through several biochemical pathways, including polyol pathway activation, increased advanced glycation end-product (AGE) formation, activation of protein kinase C, and increased hexosamine pathway flux. These mechanisms collectively contribute to oxidative stress and inflammation in tissues.
  • The duration and severity of hyperglycemia directly correlate with the development and progression of complications, emphasizing the importance of tight glycemic control with target HbA1c typically <7% for most patients.

Key Points

  • Chronic hyperglycemia is the primary driver of diabetic complications
  • Both microvascular and macrovascular complications stem from similar pathophysiologic mechanisms
  • Glycemic control is the cornerstone of preventing diabetic complications

Microvascular Complications

Diabetic Nephropathy

  • Diabetic nephropathy is characterized by progressive kidney damage beginning with hyperfiltration, followed by microalbuminuria (30-300 mg/24h), macroalbuminuria (>300 mg/24h), and eventually declining glomerular filtration rate (GFR) leading to end-stage renal disease (ESRD). The earliest detectable sign is microalbuminuria, which represents a critical point for intervention.
  • Management focuses on strict glycemic control, blood pressure management (target <130/80 mmHg), and ACE inhibitors or ARBs as first-line medications even in normotensive diabetic patients with microalbuminuria to slow disease progression.

Key Points

  • Annual screening for microalbuminuria is essential for early detection
  • ACE inhibitors/ARBs are renoprotective beyond their antihypertensive effects
  • Diabetic nephropathy is the leading cause of ESRD in the United States

Diabetic Retinopathy

  • Diabetic retinopathy progresses from non-proliferative retinopathy (microaneurysms, hemorrhages, hard exudates) to proliferative retinopathy (neovascularization, vitreous hemorrhage, retinal detachment). Diabetic macular edema can occur at any stage and is a leading cause of vision loss.
  • Regular comprehensive eye examinations are crucial: Type 1 DM patients should have initial examination within 5 years of diagnosis, while Type 2 DM patients should be examined at diagnosis and annually thereafter. Early detection and treatment with laser photocoagulation, anti-VEGF injections, or vitrectomy can prevent severe vision loss in 90% of cases.

Key Points

  • Diabetic retinopathy is the leading cause of blindness in working-age adults
  • Patients may be asymptomatic even with advanced retinopathy
  • Pregnancy can accelerate retinopathy progression

Diabetic Neuropathy

  • Diabetic neuropathy encompasses several distinct syndromes, with distal symmetric polyneuropathy (DSP) being most common, affecting 50% of diabetics after 10 years. DSP presents with symmetric, length-dependent, "stocking-glove" distribution of sensory symptoms including numbness, tingling, or neuropathic pain.
  • Autonomic neuropathy affects multiple systems causing orthostatic hypotension, gastroparesis, neurogenic bladder, erectile dysfunction, and cardiac autonomic neuropathy (CAN). CAN is particularly concerning as it may present with painless myocardial infarction and sudden cardiac death.

Key Points

  • Annual foot examinations with 10g monofilament testing are essential for all diabetic patients
  • First-line medications for painful diabetic neuropathy include pregabalin, duloxetine, and amitriptyline
  • Autonomic neuropathy significantly increases mortality risk

Memory Aid: Microvascular Complications "3N"

Nephropathy - Kidneys (microalbuminuria → proteinuria → ESRD)

Neuropathy - Nerves (sensory, motor, autonomic dysfunction)

Netinopathy - Retina (non-proliferative → proliferative)

Macrovascular Complications

Cardiovascular Disease

  • Diabetic patients have a 2-4 times higher risk of cardiovascular disease (CVD) compared to non-diabetics, with CVD accounting for approximately 65% of diabetic deaths. The pathophysiology involves accelerated atherosclerosis from hyperglycemia, insulin resistance, dyslipidemia, and inflammation.
  • Primary prevention strategies include aggressive management of multiple risk factors: glycemic control, lipid management (statins for most diabetic patients regardless of baseline LDL), blood pressure control, smoking cessation, and antiplatelet therapy when indicated.

Key Points

  • Diabetes is considered a "coronary heart disease equivalent" for risk stratification
  • Atypical or silent myocardial infarction is common due to autonomic neuropathy
  • Multiple risk factor intervention provides greater benefit than addressing single factors

Cerebrovascular Disease

  • Diabetes increases stroke risk by 1.5-3 times, with worse outcomes and higher mortality after stroke events. Both ischemic and hemorrhagic stroke risks are elevated, though ischemic strokes predominate.
  • Management focuses on comprehensive vascular risk reduction including blood pressure control (target <130/80 mmHg), statin therapy, glycemic control, and antiplatelet therapy when indicated. Carotid revascularization may be considered for significant stenosis.

Key Points

  • Diabetic patients have higher risk of recurrent stroke and poststroke dementia
  • Blood pressure control is particularly important for stroke prevention
  • Recognize and rapidly respond to TIA symptoms as stroke warning signs

Peripheral Arterial Disease

  • Peripheral arterial disease (PAD) is 2-4 times more common in diabetics, often presents atypically, and progresses more rapidly with higher rates of amputation. Classic symptoms include intermittent claudication, but many patients may be asymptomatic or present directly with tissue loss.
  • Screening involves ankle-brachial index (ABI) measurement, with values <0.9 indicating PAD. Management includes exercise programs, smoking cessation, antiplatelet therapy, statins, and revascularization when indicated. Critical limb ischemia requires urgent vascular evaluation.

Key Points

  • Annual foot examination should include pulse assessment and ABI when indicated
  • PAD significantly increases the risk of foot ulcers and amputation
  • Diabetic patients with PAD have higher cardiovascular mortality

Diabetic Foot Complications

Diabetic Foot Ulcers

  • Diabetic foot ulcers (DFUs) affect approximately 15% of diabetic patients during their lifetime and precede 85% of lower extremity amputations. The pathophysiology involves a triad of neuropathy (sensory loss leading to unnoticed trauma), peripheral arterial disease (impaired healing), and immunopathy (increased infection risk).
  • Prevention strategies include regular foot examinations, proper footwear, patient education on daily foot inspection, and prompt treatment of minor injuries. Management follows the principle of "TIME": Tissue debridement, Infection control, Moisture balance, and Edge advancement/Epithelialization.

Clinical Scenario: Diabetic Foot Ulcer

A 65-year-old male with 15-year history of type 2 diabetes presents with a 2cm ulcer on the plantar surface of his right foot under the first metatarsal head. The wound has minimal drainage, surrounding erythema, and the patient reports no pain. The wound probes to tendon.

Appropriate nursing interventions:

  1. Assess vascular status (pulses, capillary refill, ABI if indicated)
  2. Evaluate for signs of infection (temperature, WBC, erythema beyond wound margins)
  3. Classify ulcer using Wagner or University of Texas classification
  4. Implement pressure offloading with appropriate device
  5. Initiate moist wound healing principles with appropriate dressing
  6. Educate on strict glucose control to promote healing
  7. Arrange multidisciplinary care with endocrinology, podiatry, and vascular surgery as needed

Key Points

  • Offloading pressure is the most critical intervention for plantar ulcer healing
  • Wagner Grade 3 or higher ulcers (deep with abscess/osteomyelitis) require hospitalization
  • Comprehensive foot examinations should be performed at least annually

Charcot Neuropathic Osteoarthropathy

  • Charcot neuropathic osteoarthropathy is a progressive, non-infectious destruction of bones and joints resulting from neuropathy, characterized by acute inflammation followed by bone fragmentation, joint dislocation, and deformity. Early recognition is critical as the acute phase can mimic infection or cellulitis.
  • The acute phase presents with erythema, warmth, and edema, often with minimal pain due to neuropathy. The temperature differential between affected and unaffected foot is typically >2°C. Management includes strict non-weight-bearing immobilization with total contact casting until the acute phase resolves.

Key Points

  • The 6D deformities of chronic Charcot: Distended, Disorganized, Dislocated, Debris-filled, Dense bone, and Destruction
  • Differentiate from osteomyelitis using imaging (MRI) and laboratory findings
  • Surgical intervention may be required for unstable deformities or recurrent ulceration

ALERT: Red Flags for Limb-Threatening Conditions

  • Deep space infection: Crepitus, bullae, skin necrosis, severe pain, rapid progression
  • Critical limb ischemia: Rest pain, pallor, pulselessness, paresthesia, paralysis, poikilothermia
  • Acute Charcot: Acute onset erythema, warmth, swelling with minimal pain and normal WBC

These conditions require immediate referral for specialist evaluation!

Commonly Confused Points

Diabetic Complications Differentiation

Diabetic Foot Infection vs. Acute Charcot Foot

Feature Diabetic Foot Infection Acute Charcot Foot
Pain Present (may be blunted by neuropathy) Minimal or absent
Erythema Present, often with distinct borders Present, diffuse
Temperature Warm Very warm (>2°C difference from other foot)
Systemic symptoms May have fever, elevated WBC Usually absent
Ulceration Often present Usually absent initially
X-ray findings Soft tissue swelling, may have osteomyelitis Early: normal or osteopenia; Later: fragmentation, dislocation
Treatment Antibiotics, debridement Offloading, immobilization (no antibiotics)

Microvascular vs. Macrovascular Complications

Feature Microvascular Complications Macrovascular Complications
Affected vessels Capillaries, arterioles, venules Large and medium-sized arteries
Primary pathology Basement membrane thickening Atherosclerosis
Target organs Kidneys, retina, nerves Heart, brain, peripheral arteries
Unique to diabetes Yes (specific to hyperglycemia) No (accelerated but similar to non-diabetics)
Glycemic control impact Strong direct relationship Moderate relationship (multifactorial)
Screening Specific tests (microalbuminuria, retinal exam, monofilament) Risk factor assessment, symptom evaluation

Types of Diabetic Neuropathy

Type Distribution Symptoms Clinical Significance
Distal Symmetric Polyneuropathy Symmetric, length-dependent "stocking-glove" Numbness, tingling, burning, allodynia Risk for foot ulcers, falls
Autonomic Neuropathy Sympathetic and parasympathetic systems Orthostatic hypotension, gastroparesis, neurogenic bladder, erectile dysfunction Silent MI, sudden death risk
Mononeuropathy Single nerve (e.g., cranial nerve III, median, ulnar) Acute onset, focal symptoms in nerve distribution Usually self-limiting
Radiculopathy Nerve root distribution Sharp, shooting pain in dermatomal pattern Differential diagnosis with disc disease
Diabetic Amyotrophy Proximal, asymmetric (thigh, hip) Severe pain, weakness, muscle wasting May cause significant disability

Study Tips and Memory Aids

Strategic NCLEX Preparation

  • When answering NCLEX questions about diabetic complications, prioritize assessment findings that suggest acute or life-threatening conditions (e.g., critical limb ischemia, severe hyperglycemia, infection) over chronic management concerns.
  • For questions about diabetic neuropathy, remember that sensory symptoms typically precede motor symptoms, and distal symptoms precede proximal ones. This progression is key to understanding the clinical presentation and answering questions correctly.

Memory Aid: DIABETES - Complications Screening

Dilated eye exam yearly

Inspect feet at every visit

Annual comprehensive foot exam with monofilament

Blood pressure at every visit (target <130/80)

EGFR and urine albumin-to-creatinine ratio annually

Triglycerides and lipid panel annually

ECG baseline and as indicated

Smoking cessation counseling

Memory Aid: "5 P's" of Critical Limb Ischemia

Pain (rest pain, especially at night)

Pallor (pale skin, poor capillary refill)

Pulselessness (diminished or absent pulses)

Paresthesia (numbness, tingling)

Paralysis (motor weakness - late finding)

+ Poikilothermia (cold skin temperature)

Common NCLEX Pitfalls: Diabetic Complications

  • Confusing the treatment approaches for hypoglycemia vs. hyperglycemia emergencies
  • Misinterpreting neuropathic symptoms as vascular insufficiency or vice versa
  • Failing to recognize the importance of offloading pressure in diabetic foot ulcer management
  • Not prioritizing infection control in the management of diabetic foot wounds
  • Overlooking the need for cardiac evaluation in asymptomatic diabetic patients (silent ischemia)

Quick Check: Test Your Knowledge

  1. What is the earliest detectable sign of diabetic nephropathy? (Microalbuminuria)
  2. Which diabetic complication is characterized by basement membrane thickening and pericyte loss? (Diabetic retinopathy)
  3. What is the most important intervention for a neuropathic plantar foot ulcer? (Pressure offloading)
  4. Which medication class should be considered first-line for diabetic patients with microalbuminuria? (ACE inhibitors or ARBs)
  5. What distinguishes Charcot foot from infection in the acute phase? (Minimal pain, normal WBC, diffuse erythema, significant temperature difference)

Self-Assessment Checklist

  • I can explain the pathophysiologic mechanisms of diabetic complications
  • I can differentiate between microvascular and macrovascular complications
  • I can identify the key screening recommendations for each diabetic complication
  • I understand the management priorities for diabetic foot ulcers
  • I can recognize the warning signs of limb-threatening conditions
  • I can describe the progression of diabetic nephropathy and appropriate interventions
  • I can distinguish between different types of diabetic neuropathy

Remember: Understanding diabetic complications is crucial not just for passing the NCLEX but for providing life-saving care to your future patients. The knowledge you're gaining now will help you identify early warning signs, implement appropriate interventions, and educate patients on preventing devastating complications. Stay focused on mastering these concepts—your future patients are counting on your expertise!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.